• Mashup Score: 0
    MedShr docsearch - 1 year(s) ago

    MedShr docsearch gives you everything you can get from PubMed and so much more, with real time AI insights and analysis alongside your search results.

    Tweet Tweets with this article
    • #COVIDVACCINE #complications latest data with real time AI Insights @devisridhar @trishgreenhalgh @rogerkline @dr_barrett @GeorgeMonbiot @mmamas1973 @dr_benoy_n_shah @ShrillaB @gavi @DRTomlinsonEP @medshronline @DrDerekConnolly @danielgoyal @ncurzen https://t.co/rmylrRcSVw

  • Mashup Score: 0

    The choice between Basiliximab (BSX) or Anti-Thymocyte Globulin (ATG) as induction therapy in non-immunized kidney transplant recipients remains uncertain. Whilst ATG may allow steroid withdrawal and a decrease in tacrolimus, it also increases infectious complications. We investigated outcomes in non-immunized patients receiving a very low dosage of ATG versus BSX as induction. Study outcomes…

    Tweet Tweets with this article
    • Induction with a very low dose of #ATG in non-immunized recipients is safe and associated with a lower rate of #BPAR and #PTD without increasing #infectious #complications in #kidneytransplant recipients https://t.co/MKZNIKlell https://t.co/jxKH52kCq4

  • Mashup Score: 0
    CTO 2023 - 1 year(s) ago

    Join us in New York to enhance your skill set at CTO Plus: Complex CTO & Higher Risk PCI — February 23–24, 2023, at the New York Marriott Marquis. The meeting takes place on-site only. A livestream for remote viewing will not be available.Learn From World-Renowned Experts inInterventional Cardiovascular Medicine!CTO Plus 2023 encompasses complex PCI topics, including intravascular imaging and…

    Tweet Tweets with this article
    • 🔥 Fired up to attend the always impactful 💥 @crfheart #CTO2023 meeting in amazing #NYC🗽this month (https://t.co/XkWR7EmpDY): #CTO, #CHIP, #Imaging 👁️, #Calcium 🪨, #Fundamentals, #Complications, #LiveCases, #Research, and #Innovation. Who’s with me?… https://t.co/pNn4ZXvQ1a

  • Mashup Score: 6

    Growth hormone-secreting pituitary adenomas that cause acromegaly arise as monoclonal expansions of differentiated somatotroph cells and are usually sporadic. They are almost invariably benign, yet they can be locally invasive and show progressive growth despite treatment. Persistent excess of both growth hormone and its target hormone insulin-like growth factor 1 (IGF-1) results in a wide array…

    Tweet Tweets with this article
    • In this Review, we examine the #epidemiology, #pathogenesis, #diagnosis, #complications, and #treatment of #acromegaly, with an emphasis on the importance of tailoring management strategies to each patient to optimise outcomes https://t.co/2fbnM4j7oA #neuroendocrine #pituitary https://t.co/zLYs5bx44G

  • Mashup Score: 0

    This course provides a peer review forum for the discussion of complications related to brain tumor surgery. Clinical decisions, operative techniques, and equipment-related issues will be discussed in

    Tweet Tweets with this article
    • It's not too late to join your colleagues in Nashville to discuss tumor complications cases! @PrevedelloDanny believes it the best way to learn! See you there: https://t.co/XfmLQuywRC #CNSCourse #CNSTumor #complications https://t.co/FZwWc7XBeq

  • Mashup Score: 5
    CTO 2023 - 1 year(s) ago

    Join us in New York to enhance your skill set at CTO Plus: Complex CTO & Higher Risk PCI — February 23–24, 2023, at the New York Marriott Marquis. The meeting takes place on-site only. A livestream for remote viewing will not be available.Learn From World-Renowned Experts inInterventional Cardiovascular Medicine!CTO Plus 2023 encompasses complex PCI topics, including intravascular imaging and…

    Tweet Tweets with this article
    • 💥Fired up to attend the always impactful @crfheart #CTO2023 meeting in amazing #NYC🗽next month (https://t.co/UBWvf2NB6X ): #CTO, #CHIP, #Imaging 👁️, #Calcium 🪨, #Fundamentals, #Complications, #LiveCases, #Research, and #Innovation. Who’s with me?… https://t.co/D0nC4MiWIO

    • RT @agtruesdell: 💥Fired up to attend the always impactful @crfheart #CTO2023 meeting in amazing #NYC🗽next month (https://t.co/UBWvf2NB6X ):…